Mironid
5 known investors
Find your way into Mironid
Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. It focuses on developing novel therapeutics for rare diseases with high unmet clinical need.
Founders & leadership
AR
Adele RowleyinChief Scientific Officer
Investors · 5
Competitors · 5
by search overlap
Rif Care7 shared keywordsRif Care is a menstrual care brand offering plant-based period products.
Medpagetoday7 shared keywordsMedPage Today is a clinical news and information platform that provides independent coverage of medical research, healthcare policy, and professional development for U.S. healthcare practitioners. The platform publishes daily clinical news, conference coverage, investigative reports, and podcasts with strict editorial review and fact-checking standards.
Womenshealthmag7 shared keywordsWomen's Health is a media brand publishing articles, guides, podcasts, and video series on fitness, nutrition, beauty, and health topics aimed at women. It also offers subscription-based (WH+) workout and nutrition plans covering strength training, muscle building, and longevity.
Today7 shared keywordsTODAY is a morning news and lifestyle broadcast program and digital platform that delivers news, entertainment, wellness content, and lifestyle advice to American audiences. The company operates both a television show and TODAY.com, a digital destination offering news coverage, recipes, health tips, and product recommendations.
The Lanby7 shared keywordsThe Lanby curates and recommends wellness products from third-party brands across categories including supplements, fitness equipment, kitchen items, and home goods aligned with holistic health principles. The company serves consumers seeking quality wellness essentials and personalized long-term health partnerships.
Companies competing with Mironid for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Mironid do?
- Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. It focuses on developing novel therapeutics for rare diseases with high unmet clinical need.
- Who are Mironid's investors?
- Mironid's investors include Epidarex Capital, Roche Venture Fund, Sofinnova Partners, BioGeneration Ventures, Scottish National Investment Bank.